Doha: The Ministry of Public Health (MoPH) affirmed its commitment to supporting the national pharmaceutical industry in a way that meets local needs and aligns with international standards. In an effort to bolster the industry, the MoPH organized an extensive introductory meeting on the national pharmaceutical sector, attended by representatives from local pharmaceutical manufacturers, as well as private and semi-government hospitals.

According to Qatar News Agency, the meeting aimed to strengthen and develop the national pharmaceutical industries and enhance effective communication between local manufacturers and hospitals, contributing to greater medicines security. Director of the Pharmacy and Drug Control Department at the MoPH, Dr. Aisha Ibrahim Al Ansari, emphasized the ministry's dedication to showcasing the production capabilities of local pharmaceutical manufacturers, which is crucial for fulfilling local market demands while adhering to the highest global standards.

Dr. Al Ansari stated, "this meeting contributes to building a robust national pharmaceutical industry that meets the community needs, within the framework of implementing the national health strategy." Representatives from local manufacturers, including Qatar Pharma, QLife Pharma, and Qatar Pharmaceutical Industries (QPI), presented an overview of their production facilities, modern production lines, achievements, and some international accreditations for their manufacturing plants.

The participants also deliberated on mechanisms to ensure continuity of supply and recommended developing protocols for information exchange, as well as supporting training and scientific research programs. The meeting is part of the MoPH's ongoing commitment to strengthening collaboration between the public and private health sectors and supporting the national pharmaceutical industry.